EAACI Congress 2025

Back
13 - 16 June 2025 Glasgow, United Kingdom

Analysis of discontinuation of omalizumab in patients with chronic spontaneous and/or inducible urticaria in a tertiary hospital in one year

Sunday 15 Jun, 12:45 PM - 12:45 PM Glasgow, United Kingdom